###begin article-title 0
Metabolic Fingerprints of Altered Brain Growth, Osmoregulation and Neurotransmission in a Rett Syndrome Model
###end article-title 0
###begin p 1
Conceived and designed the experiments: NL AV PC. Performed the experiments: NL VS. Analyzed the data: NL. Contributed reagents/materials/analysis tools: LV PC. Wrote the paper: NL AV LV.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 92 97 <span type="species:ncbi:9606">girls</span>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
Rett syndrome (RS) is the leading cause of profound mental retardation of genetic origin in girls. Since RS is mostly caused by mutations in the MECP2 gene, transgenic animal models such as the Mecp2-deleted ("Mecp2-null") mouse have been employed to study neurological symptoms and brain function. However, an interdisciplinary approach drawing from chemistry, biology and neuroscience is needed to elucidate the mechanistic links between the genotype and phenotype of this genetic disorder.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 611 614 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 923 928 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1110 1115 1110 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 934 939 <span type="species:ncbi:10090">mouse</span>
###xml 1121 1126 <span type="species:ncbi:10090">mouse</span>
We performed, for the first time, a metabolomic study of brain extracts from Mecp2-null mice by using high-resolution magnetic resonance spectroscopy. A large number of individual water-soluble metabolites and phospholipids were quantified without prior selection for specific metabolic pathways. Results were interpreted in terms of Mecp2 gene deletion, brain cell function and brain morphology. This approach provided a "metabolic window" to brain characteristics in Mecp2-null mice (n = 4), revealing (i) the first metabolic evidence of astrocyte involvement in RS (decreased levels of the astrocyte marker, myo-inositol, vs. wild-type mice; p = 0.034); (ii) reduced choline phospholipid turnover in Mecp2-null vs. wild-type mice, implying a diminished potential of cells to grow, paralleled by globally reduced brain size and perturbed osmoregulation; (iii) alterations of the platelet activating factor (PAF) cycle in Mecp2-null mouse brains, where PAF is a bioactive lipid acting on neuronal growth, glutamate exocytosis and other processes; and (iv) changes in glutamine/glutamate ratios (p = 0.034) in Mecp2-null mouse brains potentially indicating altered neurotransmitter recycling.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
This study establishes, for the first time, detailed metabolic fingerprints of perturbed brain growth, osmoregulation and neurotransmission in a mouse model of Rett syndrome. Combined with morphological and neurological findings, these results are crucial elements in providing mechanistic links between genotype and phenotype of Rett syndrome. Ultimately, this information can be used to identify novel molecular targets for pharmacological RS treatment.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Rett1">[1]</xref>
###xml 313 316 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Hagberg1">[2]</xref>
###xml 374 377 374 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Amir1">[3]</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 638 641 638 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Shahbazian1">[4]</xref>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zoghbi1">[5]</xref>
###xml 187 192 <span type="species:ncbi:9606">girls</span>
Rett syndrome (RS) is an X-linked neurological disorder that almost exclusively affects the female population. RS is the leading cause of profound mental retardation of genetic origin in girls. First described in the 1960s by A. Rett [1], this disorder has been recognized as a neurological syndrome in the 1980s [2], and its genetic basis has been discovered very recently [3]. In up to 96% of all classic cases, RS is caused by mutations or deletions in MECP2, a gene encoding for the MECP2 (methyl cytosine phosphate dinucleotide guanine binding) protein which acts as a transcriptional repressor critical for normal neuronal function [4], [5].
###end p 9
###begin p 10
Like other genetic disorders, RS is characterized by abnormal expression of a gene, resulting in a clinical phenotype. Consequently, research on genotype-phenotype correlation, i.e. the association between the presence of a certain mutation (genotype) and the resulting traits (phenotype), is crucial for establishing the basic link between altered gene expression and the disorder. Beyond genotype-phenotype correlation studies, the elucidation of actual mechanisms leading from particular genetic changes to specific symptoms is a rather challenging task. Multiple levels are involved including gene transcription, protein expression and posttranslational protein modification, all resulting in changes of the complex metabolic network that determines how cells perform specific tasks. For this reason, an interdisciplinary approach drawing from biochemistry, molecular biology, neuroscience and medicine is needed, with particular emphasis on the comprehensive analysis of cell metabolism.
###end p 10
###begin p 11
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zoghbi1">[5]</xref>
###xml 267 270 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Shahbazian1">[4]</xref>
###xml 272 275 272 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zoghbi1">[5]</xref>
###xml 347 350 347 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Hagberg2">[6]</xref>
###xml 661 664 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Armstrong1">[7]</xref>
###xml 665 668 665 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Subramaniam1">[9]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Hagberg3">[10]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Hagberg4">[11]</xref>
###xml 915 919 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Gotoh1">[12]</xref>
###xml 1020 1023 1020 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Armstrong1">[7]</xref>
###xml 1147 1152 1147 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 1279 1282 1279 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Shahbazian1">[4]</xref>
###xml 1427 1432 1427 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1432 1435 1432 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zoghbi1">[5]</xref>
###xml 1437 1441 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Dani1">[13]</xref>
###xml 1442 1446 1442 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nuber1">[16]</xref>
###xml 1465 1470 1465 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1507 1511 1507 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Dani1">[13]</xref>
###xml 1512 1516 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nuber1">[16]</xref>
###xml 1727 1730 1727 1730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Shahbazian1">[4]</xref>
###xml 1732 1735 1732 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zoghbi1">[5]</xref>
###xml 1737 1741 1737 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nelson1">[17]</xref>
###xml 1742 1746 1742 1746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nagai1">[19]</xref>
###xml 223 228 <span type="species:ncbi:9606">girls</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
###xml 1212 1220 <span type="species:ncbi:9606">patients</span>
###xml 1359 1364 <span type="species:ncbi:10090">mouse</span>
###xml 1476 1481 <span type="species:ncbi:10090">mouse</span>
While the spectrum of postnatal neurological disorders caused by MECP2 mutations is rather broad [5], a number of behavioral, neuroanatomical and neurochemical features are consistently associated with classic RS. Affected girls appear to be normal until age 6-18 mo [4], [5]. Their neurological development is then arrested and begins regressing [6]. Symptoms include decelerating head growth, resulting in autistic features, loss of skills such as speech and purposeful hand use, irregular breathing patterns, and in many cases seizures. Morphometric and volumetric studies of subjects with RS showed microcephaly and size reductions of certain brain regions [7]-[9]. In fact, the most recent 'clinically applicable diagnostic criteria in RS' include 'a deceleration of head growth of two standard deviations' as one of the consensus criteria [10], [11]. Cerebellar atrophy has been detected in adult RS patients [12]. Histological investigations have revealed a reduction in neuron size and in dendritic arborization [7]. Several groups have conducted genotype-phenotype correlation studies to determine whether different types of mutations in MECP2 can account for the variability of clinical features in RS patients. However, these studies have yielded inconsistent results [4]. To enable more systematic and better-controlled investigations, transgenic mouse models have been engineered that are characterized by mutated Mecp2[5], [13]-[16]. Among these, the Mecp2-null mouse model is widely accepted [13]-[16]. All these models have been employed to study neurological symptoms, respiration, synaptic transmission, neurotransmitter receptors, neuronal architecture and morphology, but also the involvement of astrocytes [4], [5], [17]-[19].
###end p 11
###begin p 12
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 687 690 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Gokcay1">[21]</xref>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Pan1">[23]</xref>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1035 1036 1035 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1042 1044 1042 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
###xml 1059 1067 1059 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">extracts</italic>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
###xml 760 768 <span type="species:ncbi:9606">patients</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
In a previous study, we have used the Mecp2-null mouse model to determine the cerebral endophenotype associated with the lack of the Mecp2 protein in brain by using in vivo magnetic resonance imaging (MRI) and spectroscopy (MRS) [20]. Volumetric analysis of MRI images have revealed important neuroanatomical anomalies such as a size reduction of the whole brain and of structures involved in cognitive and motor functions (cerebellum and motor cortex) in Mecp2-/y vs. wild-type mice. These observations reflect in part changes detected previously in RS patients. Several groups have used localized 1H MRS methods to measure variations of N-acetylaspartate (NAA), choline, myo-inositol (myo-Ins) and glutamate/glutamine levels in different brain regions of RS patients [21]-[23]. Our in vivo MRS studies have yielded neurochemical differences between wild-type and Mecp2-/y mice, although the number of metabolites that can be quantitated in vivo is rather limited. We now present a detailed metabolomic study based on high-resolution 1H and 31P MRS of brain extracts.
###end p 12
###begin p 13
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Ham1">[24]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lutz1">[25]</xref>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MeCP2</italic>
###xml 538 544 <span type="species:ncbi:9606">humans</span>
The principal purpose of this pilot study is to provide a comprehensive analysis of the brain metabolic phenotype associated with Mecp2 deletion [24], and to relate these results to morphological and neurological characteristics. Like other 'omics' (e.g. genomics, proteomics), metabolomics has the benefit of simultaneously providing a broad overview of molecular processes without prior selection for specific pathways [25]. Notably, we report the first phospholipidomic analysis of brain tissue characterized by a mutation of MeCP2 in humans or animals. This approach permits the detection of characteristic "fingerprints" of metabolic processes. These in turn provide a sound basis for further mechanistic studies by establishing well-founded hypotheses. Ultimately, the detection of metabolic processes related to RS features such as cerebral atrophy and neuronal dysfunction should enable the identification of molecular targets for more efficient pharmacological treatment of the disorder.
###end p 13
###begin title 14
Results
###end title 14
###begin p 15
###xml 269 277 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">multiple</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Significant differences between Mecp2-deficient mice and controls were detected for a number of metabolites. While the presentation of results given below is organized according to biochemical categories, it should be kept in mind that most metabolites are involved in multiple metabolic pathways and processes. Thus, the context provided for individual metabolites should not be considered exhaustive.
###end p 15
###begin title 16
Mecp2 deletion alters the brain profile of choline-containing phospholipids and cardiolipin
###end title 16
###begin p 17
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lutz1">[25]</xref>
###xml 710 711 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 742 748 742 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000157-g001">Fig. 1</xref>
###xml 879 886 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t001">Table 1</xref>
###xml 1198 1202 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 1308 1315 1308 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t001">Table 1</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
Our previous in vivo 1H MRS study revealed altered relative levels of total choline (tCho) in Mecp2-deficient mice vs. controls [20], where tCho represents several metabolites predominantly involved in choline phospholipid metabolism (choline, Cho; phosphocholine, PC; glycerophosphocholine, GPC), plus substantial contributions from phosphoethanolamine and taurine [25]. The phosphodiester, glycerophosphocholine, is a phospholipid (PL) degradation product while choline and the phosphomonoester, phosphocholine, are both phospholipid anabolites and catabolites. Since individual choline compounds and phospholipid classes cannot be quantitated by in vivo MRS, we determined their (absolute) tissue levels by 1H MRS of whole-brain extracts (Fig. 1). Each of the three choline species mentioned above showed a trend towards decreased levels in Mecp2-deficient mice vs. controls (Table 1); the difference was close to statistical significance for choline (ca. -40%; p = 0.077), but not for the phosphorylated choline species. For the sum of these three choline compounds, a slight decrease was observed (not significant), in agreement with our previous in vivo results obtained at a short echo time [20]. Interestingly, the PC/GPC ratio was clearly increased by 30% (p = 0.034), mostly due to a GPC decrease (Table 1).
###end p 17
###begin p 18
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
###xml 72 78 72 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000157-g002">Fig. 2</xref>
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
###xml 385 390 385 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t002">Table 2</xref>
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s003">Table S1</xref>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
31P MRS was able to distinguish 16 phospholipid classes and subclasses (Fig. 2), fourteen of which were successfully assigned. The analysis of PL profiles by 31P MRS showed significant differences in PL levels between Mecp2-deficient mice and controls solely for choline-containing PL (diacyl-phosphatidylcholine, PtdC; alkyl-acyl-phosphatidylcholine, AAPtdC; choline plasmalogen, PtdCplasm; lyso- phosphatidylcholine, lyso-PtdC) (Table 2; see also Table S1 for cardiolipin, CL).
###end p 18
###begin p 19
###xml 244 249 244 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 430 435 430 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 483 490 483 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t002">Table 2</xref>
###xml 506 511 506 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 579 584 579 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 690 695 690 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 772 775 772 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tot</sub>
###xml 928 935 928 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t002">Table 2</xref>
###xml 470 475 <span type="species:ncbi:10090">mouse</span>
All other phospholipid classes and subclasses determined were present at very similar levels in the brains of both animal groups (diacyl-phosphatidylethanolamine, PtdE; alkyl-acyl-phosphatidylethanolamine, AAPtdE; ethanolamine plasmalogen, PtdEplasm; sphingomyelin, SM; lyso-sphingomyelin, lyso-SM; phosphatidylserine, PtdS; phosphatidylinositol, PI; phosphatidic acid, PtdA; phosphatidylglycerol, PtdG). Choline plasmalogen (PtdCplasm) was decreased in Mecp2-deficient mouse brain (Table 2); however, PtdCplasm values may be less accurate than the other PL values since the PtdCplasm peak areas measured may be influenced by the presence of the large PtdC signal directly upfield from PtdCplasm. PtdS and PtdE showed a trend towards increased values (not significant). PLtot (total phospholipids) levels did not vary between groups, nor did the molar ratio between choline and ethanolamine-containing phospholipids, PC-L/PE-L (Table 2). As a matter of fact, molar fractions of phospholipids are a direct measure of the balance of phospholipid composition that affects the fluidity and function of membranes (Farooqui and Horrocks 2001).
###end p 19
###begin title 20
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Cerebral profiles of neurotransmitters in Mecp2-null mice
###end title 20
###begin p 21
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Purves1">[26]</xref>
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 805 812 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t001">Table 1</xref>
###xml 1176 1180 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Viola1">[27]</xref>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
Choline, introduced above as a phospholipid metabolite, is also involved in neurotransmitter metabolism as it is an anabolite and catabolite of acetylcholine. Other neurotransmitters and their metabolites are closely linked to glucose (glc) metabolism. Glutamate (glu), generally acknowledged to be the most important transmitter for normal brain function [26], can be produced from the citric acid cycle following pyruvate formation from glucose. We did not detect a significant difference in glutamate between Mecp2-deficient and control mice based on 1H spectra of brain extracts. However, the presynaptic precursor of glutamate, glutamine (gln), was significantly increased in Mecp2-deficient mice by almost 40%. The glutamine/glutamate ratio also was significantly increased in Mecp2-deficient mice (Table 1). Aspartate (asp) is a neurotransmitter and a glutamate metabolite, and, like glutamate, does not differ between Mecp2-deficient and control mice. Similarly, the inhibitory neurotransmitter, gamma-aminobutyrate (GABA), is derived from glutamate and only shows an insignificant decrease in Mecp2-deficient vs. control mice. Glycine (gly), another neurotransmitter [27], shows almost identical concentrations in both groups.
###end p 21
###begin title 22
Mecp2 deletion alters cerebral osmolyte profiles
###end title 22
###begin p 23
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Baslow1">[28]</xref>
###xml 277 284 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t001">Table 1</xref>
###xml 408 411 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 594 601 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t001">Table 1</xref>
###xml 1043 1044 1039 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1076 1080 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 1413 1414 1409 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1432 1433 1428 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1502 1507 1498 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1547 1554 1543 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000157-t001">Table 1</xref>
###xml 1702 1706 1698 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Macala1">[29]</xref>
###xml 1805 1809 1801 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Wu1">[30]</xref>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 1511 1515 <span type="species:ncbi:10090">mice</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
NAA is considered a neuronal marker and has also been proposed to act as an osmolyte [28]. NAA is involved in asp metabolism and lipid synthesis, and was found in large quantities in mouse brain (ca. 4 micromol/g). However, no differences were detected between the two groups (Table 1). Besides GPC and glutamine mentioned above, we quantitated two additional compounds known as osmolytes, taurine (tau) and myo-Ins. This polyol that is also important in phospholipid (phosphatidylinositol) metabolism, was decreased by one third in Mecp2-deficient mice (p = 0.034 for both significance tests, Table 1). In contrast, there was no difference in taurine levels between the two groups studied. Neither the NAA and ketone body-derived metabolite, acetate (ac), nor the glycolysis products, lactate (lac) and alanine (ala), nor citric acid cycle-derived succinate (suc) were different for the two groups analyzed. In a previous paper, we raised the possibility that the NAA signal measured by in vivo MRS may overlap with an unresolved signal from N-acetylaspartylglutamate (NAAG) [20]. The latter should be readily detectable as a separate resonance in brain extract spectra. Nevertheless, we did not find any peak next to NAA that would be intense enough to explain the additional signal measured in vivo (max. 5-6% of NAA). Therefore, the extra peak observed in vivo is, in all likelihood, not due to NAAG. Another N-acetyl compound, N-acetylneuraminate (NANA) or sialic acid, is moderately decreased in Mecp2-/y mice (near significance, p = 0.077, Table 1). NANA is synthesized from glucose and is involved in the synthesis of gangliosides that are implicated in signal transduction in eukaryotic cells [29]. Knockout mice lacking the major gangliosides of brain are highly susceptible to induced seizures [30]; however, little is known about a specific role of NANA in Rett syndrome.
###end p 23
###begin title 24
Discussion
###end title 24
###begin p 25
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
A metabolic pattern that is based on a number of metabolites implicated in a common pathway can be considered a "fingerprint" of the metabolic process involved. Our metabolomic analysis revealed that the concentrations of several brain metabolites involved in different pathways varied significantly between Mecp2-null mice and controls. The biochemical processes include primarily membrane lipid metabolism, osmoregulation and glutamatergic neurotransmission. These will be interpreted in the context of morphological, neurological and functional differences between normal brains and brains characterized by Mecp2 deletion.
###end p 25
###begin title 26
###xml 74 78 <span type="species:ncbi:10090">mice</span>
How are membrane phospholipids and brain (cell) growth linked in Mecp2-/y mice?
###end title 26
###begin p 27
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MECP2</italic>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Armstrong1">[7]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nagai1">[19]</xref>
###xml 1144 1148 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lekman1">[31]</xref>
###xml 1149 1153 1149 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Papadimitriou1">[33]</xref>
###xml 579 587 <span type="species:ncbi:9606">patients</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
To our knowledge, the present study contains the first detailed quantitative analysis of membrane phospholipid classes and subclasses (phospholipidomics) in brain tissue with a mutated Mecp2 or MECP2 gene. PL metabolism plays an essential role in cell growth since PL form the matrix of cell membranes, and membrane synthesis is indispensible for cell growth. In fact, brain growth defects resulting in decreased head size and reduced neuronal cell size are one of the hallmarks of RS [7]. Global reduction in brain size and several of the morphological anomalies detected in RS patients have also been observed in the Mecp2-deficient mice used in this study [20]. Moreover, knockdown of Mecp2 levels in dissociated embryonic non-neuronal cells from mice has been shown to reduce their proliferation [19]. These effects point to growth perturbation in Mecp2-deficient brain tissue, and should therefore be reflected by parameters characterizing the biosynthesis and degradation of cellular membranes. Nonetheless, studies of cerebral membrane lipids in RS have been scarce, and have not included quantitation of individual phospholipid classes [31]-[33].
###end p 27
###begin p 28
###xml 88 97 88 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s005">Figure S1</xref>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s005">Figure S1</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Baburina1">[34]</xref>
###xml 586 590 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zhang1">[35]</xref>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
The individual steps of PtdC synthesis and degradation are well known (Kennedy pathway, Figure S1), and the role of PtdC turnover in membrane production and cell growth is well established. Therefore, the PtdC metabolite pattern observed in Mecp2-deficient mouse brain can be interpreted in terms of membrane PtdC turnover and cell growth, as outlined in the legend to Figure S1. The metabolic fingerprint of a reduced PtdC turnover rate indicates that the brain cells of Mecp2-deficient mice possess a reduced potential to boost PtdC production when cells are in a growing state [34], [35]. This may limit the ability of cells to grow, a mechanism potentially underlying brain growth arrest in Mecp2-deficient mice (see scheme below).
###end p 28
###begin p 29
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Johnston1">[36]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nagai1">[19]</xref>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 758 768 758 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">discussion</xref>
###xml 1017 1025 1017 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s004">Table S2</xref>
###xml 1055 1060 1055 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Westergaard1">[37]</xref>
###xml 1243 1248 1243 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1461 1465 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Kimelberg1">[38]</xref>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 532 537 <span type="species:ncbi:10090">mouse</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 1252 1256 <span type="species:ncbi:10090">mice</span>
Autopsy of both RS patients and Mecp2 mutant mice has revealed that the brain size is reduced without reduction of the number of neurons [36]. However, the size and dendritic arborization of neurons are reduced. On the other hand, there are up to ten times less neurons than glial cells (mainly astrocytes) in the brain. Recently published evidence suggests that, in fact, suppression of astrocyte growth may contribute to microcephaly in RS [19]. Thus, the choline PL pattern suggesting reduced growth potential in Mecp2-deficient mouse brain may represent in part non-neuronal cells. Indeed, reduced levels of the astrocyte marker, myo-inositol, in the brains of Mecp2-/y mice would be consistent with the assumption of a reduced number of astrocytes (see discussion of osmolytes below). While the interpretation of our PtdC data in terms of reduced cell growth is straight forward and rather compelling, the extent to which astrocytes and neurons are responsible for growth reduction awaits further clarification (Table S2). Experiments on co-cultured Mecp2-/y astroglial cells and neurons could be performed to study the relationship between metabolism and growth in each cell type [37]. Immunohistochemistry of brain tissue sections from Mecp2-/y mice may be employed to test the hypothesis of a more pronounced growth impairment in astrocytes vs. neurons, although correct quantitation of astrocytes may be rather difficult for reasons outlined elsewhere [38].
###end p 29
###begin title 30
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Potential role of PAF-remodeling in neurotransmission of Mecp2-deficient mice
###end title 30
###begin p 31
###xml 391 400 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s006">Figure S2</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Bazan1">[39]</xref>
###xml 666 674 666 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s004">Table S2</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Bazan1">[39]</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
PL metabolism is not only essential to cell growth. PL remodeling plays an important role in the generation of lipid messengers and in intracellular signaling. The characteristic differences in choline PL containing diacyl and acyl-alk(en)yl moieties between Mecp2-deficient mice and controls point to modifications of the platelet activating factor (PAF) remodeling pathway or "PAF cycle" (Figure S2) [39]. PAF is an acyl-alkyl PL that modulates a range of cellular processes. PAF effects relevant to the CNS may include enhancement of glutamate exocytosis, neuronal migration, memory formation, and collapse of growth cones essential to the formation of synapses (Table S2) [39]. While our results support the hypothesis of an altered PAF cycle in the Mecp2-null mouse brain, we have no direct evidence of changed PAF concentrations since PAF levels are below the detection threshold of our MRS experiments. Highly sensitive techniques such as mass spectrometry should be employed to reveal whether the levels of PAF (and a number of PAF metabolites) are indeed modified as a result of the perturbations detected in this report. This would be of particular interest considering that PAF is known to activate excitatory synapses by increasing presynaptic glutamate release. Future studies have to determine if PAF plays a role in RS.
###end p 31
###begin title 32
Mecp2 deletion causes characteristic changes in glutamate metabolism
###end title 32
###begin p 33
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Johnston2">[40]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Segovia1">[41]</xref>
###xml 623 632 623 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s001">Figure S3</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Stanimirovic1">[42]</xref>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Newsholme1">[43]</xref>
###xml 1044 1052 1044 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s004">Table S2</xref>
###xml 1054 1058 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Shokati1">[44]</xref>
###xml 1060 1064 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zwingmann1">[45]</xref>
###xml 1169 1178 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s001">Figure S3</xref>
###xml 1319 1323 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Naidu1">[22]</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 164 169 <span type="species:ncbi:9606">girls</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 1242 1250 <span type="species:ncbi:9606">patients</span>
Altered glutamine/glutamate ratios found in the Mecp2-null mouse brain may be explained based on previously published evidence of heightened excitatory activity in girls with RS [40]. The latter finding indicates that glutamate production and release from neurons are enhanced, while normal postsynaptic signal transduction may be disrupted due to overexcitation by increased glutamate release. Perturbed signaling and/or dysregulation mediated by astrocyte-associated glutamate receptors [41] may trigger increased glutamate uptake and glutamate-glutamine conversion in astrocytes, increasing glutamate-glutamine cycling (Figure S3). This would be consistent with (i) data showing an increase in metabolic activity in glia upon increased glutamate release from neurons [42], and (ii) previously reported reduction of brain ATP levels in Mecp2-null mice [20] since ATP is also consumed in the synthesis of glutamine from glutamate [43]. Glutamate levels may be kept constant by compensatory glutamate synthesis from glucose and by anaplerosis (Table S2) [44], [45]. In fact, the glutamate-glutamine cycle and neuronal activity are tightly linked to glucose metabolism (Figure S3), and elevated glutamate concentrations found in the CSF of RS patients have also been interpreted in terms of enhanced glucose utilization [22].
###end p 33
###begin p 34
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Nelson1">[17]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Johnston2">[40]</xref>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 747 749 747 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Patel1">[46]</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
An alternative explanation for increased glutamine levels in Mecp2-null mice may be a reduction in glutaminase activity, caused by a decreased need for glutamate neurotransmitter production due to a reduced number of synapses [17]. The latter might be a consequence of reduced dendritic arborization [40]. Also in this model, compensatory glutamate synthesis may maintain stable glutamate levels as suggested above. While a perturbation of the glutamate-glutamine cycle in the Mecp2-null mouse brain is well supported by our data, mechanistic details remain to be elucidated. A quantitative investigation of the relationship between glutamate-glutamine cycling, glucose and energy metabolism in RS would have to include flux measurements based on 13C-labeled glucose as a precursor, and would also have to consider a possible role of GABA [46].
###end p 34
###begin title 35
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Osmoregulation is perturbed in Mecp2-deficient mice
###end title 35
###begin p 36
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myo</italic>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 741 744 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 813 817 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zwingmann1">[45]</xref>
###xml 928 933 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 950 953 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 1016 1019 1008 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 1180 1188 1172 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s004">Table S2</xref>
###xml 1439 1443 1431 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Brand1">[47]</xref>
###xml 1601 1606 1593 1598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1688 1691 1680 1683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 1760 1764 1752 1756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 1774 1777 1766 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 1945 1948 1937 1940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 2027 2031 2019 2023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Kreis1">[48]</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1374 1378 <span type="species:ncbi:10090">mice</span>
###xml 1837 1845 <span type="species:ncbi:9606">patients</span>
###xml 2018 2026 <span type="species:ncbi:9606">children</span>
Myo-inositol levels were markedly decreased in Mecp2-deficient mice vs. controls, in both in vivo [20] and in vitro MRS measurements. Among all the water-soluble compounds quantitated in this study, the myo-inositol decrease and glutamine increase occurred with the highest statistical significance. In addition, the levels of both compounds were negatively correlated for all samples combined (p = 0.05, Spearman-Rank test), and myo-inositol was decreased by about the same amount (1.21 micromol/g tissue wet weight) as glutamine was increased (1.16 micromol/g). Since both compounds exert an osmoregulatory function, one may speculate that the increased glutamine accumulation discussed above may have triggered a compensatory decrease in myo-inositol. Such an effect has been described for cultured astrocytes [45], and may also occur when intracellular glutamine concentration is increased due to other mechanisms caused by Mecp2-deletion. Since myo-inositol is considered to be an astrocyte marker, a decreased myo-inositol level in Mecp2-deficient mice may alternatively indicate a lower number of astrocytes rather than a compensation for glutamine increase (see above and Table S2). However, a drastic reduction of the number of astrocytes vs. neurons is unlikely because in this case, a significant decrease in creatine would have been observed for Mecp2-deficient mice as creatine is more expressed in astrocytes than in neurons [47]. Further studies are necessary to clarify this point, as suggested above in the discussion of PL metabolism and cell growth. Future studies with alternative Mecp2 mutations (nonsense/missense, overexpression) should reveal whether the observed myo-inositol effect is specific to the particular animal model employed [20]. Reduced myo-inositol levels have not been reported in the brains of RS patients to date; however, only a few case reports are available on subjects with variable age, while brain myo-inositol concentrations are known to change with age even in healthy children [48].
###end p 36
###begin title 37
Conclusion
###end title 37
###begin p 38
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 375 383 375 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s004">Table S2</xref>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1107 1112 1107 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 447 452 <span type="species:ncbi:10090">mouse</span>
The quantitative analysis of a large number of brain metabolites allowed us to obtain, for the first time, a comprehensive characterization of the metabolic phenotype associated with Mecp2 mutation. Most importantly, metabolic fingerprints of reduced choline phospholipid turnover were detected, implying diminished cell growth in agreement with reduced brain size (see also Table S2). Moreover, indicators of altered osmoregulation in Mecp2-null mouse brain suggest another link to changes in brain size, potentially caused by neurons and astrocytes. In addition, changed neurotransmitter metabolism hints at specific mechanisms of brain dysfunction due to Mecp2 deletion. These hypotheses open new avenues for studying the genotype-phenotype correlation in RS, and for the identification of novel molecular targets for more efficient pharmacological RS treatment. They also serve as a basis for future studies investigating brain metabolism across the age spectrum of the animals, including measurements at a presymptomatic stage with the potential to distinguish between primary and secondary effects of Mecp2 deletion.
###end p 38
###begin title 39
Materials and Methods
###end title 39
###begin title 40
Animals
###end title 40
###begin p 41
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 73 82 73 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1-1Bird</sup>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 941 946 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Saywell1">[20]</xref>
###xml 1170 1175 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1409 1413 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Picker1">[49]</xref>
###xml 1441 1446 1441 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 407 413 <span type="species:ncbi:9606">humans</span>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 596 602 <span type="species:ncbi:9606">humans</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
Experiments were performed using the mouse model strain B6.129P2(C)-Mecp2tm1-1Bird as described previously [20]. Briefly, the mice obtained from Jackson Laboratory were maintained on a C57BL/6 background. Hemizygous mutant males were generated by crossing heterozygous knockout females to C57BL/6 males. All experiments were performed in hemizygous Mecp2-deficient males of 5-8 weeks of age. Although RS in humans predominantly affects female patients, most researchers use Mecp2-/y male mice for their studies. This choice is dictated by the fact that the Mecp2 gene is X-linked in mouse and in humans, and females will thus have a different amount of normally Mecp2-expressing cells depending on their X-chromosome inactivation profile. Since the proportion of Mecp2-deleted X chromosomes that will be inactivated in a given female animal is unpredictable, we decided to use Mecp2-/y male mice that correspond to a complete absence of the Mecp2 gene product in all cells (i.e., a real null phenotype) [20]. One consequence of complete Mecp2 suppression is that these animals are extremely frail, and therefore are difficult to reproduce in large numbers. Hence, while Mecp2-/y males are a widely accepted RS model, it is not an ideal model. Interestingly, a recent publication comparing a male and a female RS model demonstrated that both models exhibited very similar somatic growth and behavioral changes [49]. In this pilot study, four Mecp2-/y mice and four C57BL/6 controls were used. The experimental procedures were carried out in keeping with the European Guidelines for the Care and Use of Laboratory Animals (Council Directive 86/6009/EEC).
###end p 41
###begin title 42
Sample preparation
###end title 42
###begin p 43
###xml 577 578 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 484 491 <span type="species:ncbi:3879">Lucerne</span>
Animals were sacrificed by cervical dislocation. The brain was swiftly and entirely removed through an incision in the skull, freeze-clamped, weighed, and stored at -80degreesC until extraction with methanol/chloroform/water (4:4:4 ml). The frozen brain was broken up into several pieces in a mortar under liquid nitrogen. The brain pieces obtained were consecutively added to 4 ml ice-cold methanol and immediately homogenized using a Polytron tissue homogenizer (Kinematica, Kriens-Lucerne, Switzerland). The sample was incubated on ice for 15 min, then 4 ml of ice-cold CHCl3 and 4 ml 4degreesC water were added sequentially, under vigorous shaking after each addition. Samples were thoroughly vortexed and placed at -20degreesC overnight for phase separation. Subsequent centrifugation at 11,000 rpm (ca. 13,000 g at max. radius) in a Sorvall Evolution RC centrifuge (Thermo Electron Corporation, Waltham, MA, USA) for 40 min at 4degreesC completed the phase separation.
###end p 43
###begin p 44
###xml 379 380 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 440 444 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lutz2">[50]</xref>
###xml 483 484 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 510 513 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ca.</italic>
###xml 674 675 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 769 770 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 776 777 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 827 829 821 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
Solvents were evaporated from the chloroform/methanol phase under a nitrogen stream, and methanol was removed from the water/methanol phase by bubbling nitrogen through the solution while samples were kept on ice. The aqueous solution was lyophilized overnight, and both lyophilizate and lipid samples were stored at -80degreesC. For NMR spectroscopy, lipids were dissolved in a 2H-chloroform/methanol/water solution as described elsewhere [50]. The lyophilizate was redissolved in D2O, and pH was adjusted to ca. 7.0. The sample was placed in a 5-mm Wilmad NMR tube (528-PP; Carlo Erba-SDS, Val de Reuil, France) containing a stem coaxial insert (2 mm O.D.) filled with a D2O solution (pH 7.7) of 20 mM sodium 3-(trimethylsilyl)-2,2',3,3'-tetradeuteropropionate (TSP-d4) for 1H MRS, and 20 mM methylenediphosphonate (MDP) for 31P MRS, for chemical-shift referencing and quantitation. Chemicals were purchased from Sigma-Aldrich (Saint Quentin, Fallavier, France), except for a number of phospholipids used for MRS signal assignment (Doosan Serdary Research, Toronto, ON, CA).
###end p 44
###begin title 45
NMR spectroscopy
###end title 45
###begin p 46
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
###xml 231 238 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s002">Text S1</xref>
1H and 31P NMR spectra at 400.1 and 162.0 MHz, respectively, were obtained on a 9.4 T AVANCE 400 WB FT-NMR spectrometer from Bruker (Wissembourg, France), and analyzed with Bruker's Topspin software (for more technical details see Text S1). Metabolite concentrations are given as micromol/g brain tissue (wet weight). In addition, ratios of metabolite levels are presented where appropriate.
###end p 46
###begin title 47
Statistics
###end title 47
###begin p 48
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lilliefors1">[51]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Sokal1">[52]</xref>
###xml 607 608 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 800 808 800 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s003">Table S1</xref>
The statistical methods used to detect significant differences and correlations between groups included nonparametric tests (Statview 5.0.1, Cary, NC, USA). Parametric tests such as analysis of variance are appropriate only where the conditions of equal variances and normal distribution are met. However, Statview's F-test procedure yielded unequal variances for several metabolite concentrations and metabolite ratios, and common tests for normal distribution do not give meaningful results when applied to small sample groups [51], [52]. Consequently, we consistently used the nonparametric Mann-Whitney U test to determine the significance of differences between two groups, and the nonparametric Spearman-Rank test for correlations between metabolite levels (for further statistical details see Table S1).
###end p 48
###begin title 49
Supporting Information
###end title 49
###begin p 50
Technical details and parameters for NMR spectrum acquisition and evaluation
###end p 50
###begin p 51
(0.03 MB DOC)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
Comparison of statistical results from parametric vs. nonparametric tests
###end p 53
###begin p 54
(0.04 MB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Pathways and potential biochemical/biological effects associated with metabolites measured in brains of Mecp2-/y and control mice.
###end p 56
###begin p 57
(0.02 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zhang1">[35]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zhang1">[35]</xref>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Baburina1">[34]</xref>
###xml 787 791 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Tome1">[53]</xref>
###xml 1076 1082 1076 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">direct</italic>
###xml 1110 1114 1110 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Baburina1">[34]</xref>
###xml 1116 1120 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zhang1">[35]</xref>
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Tome1">[53]</xref>
###xml 1128 1132 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lykidis1">[54]</xref>
###xml 1166 1173 1166 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">resting</italic>
###xml 1267 1274 1267 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">growing</italic>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zhang1">[35]</xref>
###xml 1460 1464 1460 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Lykidis1">[54]</xref>
###xml 1525 1530 1525 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 1784 1788 1784 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Zhang1">[35]</xref>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 1536 1541 <span type="species:ncbi:10090">mouse</span>
The Kennedy pathway of phosphatidylcholine synthesis and degradation. Levels of metabolites that were significantly increased (decreased) in the brains of Mecp2-deficient mice vs. controls are indicated by upward (downward) arrows (no difference was detected for underlined metabolites). Cells regulate membrane PtdC turnover by coordinating the opposing actions of PtdC synthesis (center) and PtdC degradation (left) [35]. In this way, resting cells (that constitute the majority of adult brain cells) rapidly synthesize and degrade PtdC, maintaining a constant PtdC mass [35]. During this stationary PtdC turnover that requires efficient PtdC degradation, cells tend to sustain relatively high levels of the PtdC degradation product, GPC, with PC/GPC ratios being relatively low [34], [53]. Thus, the combination of high PtdC levels and PC/GPC ratios indicates low PtdC turnover, in agreement with an established model described elsewhere (refs. 32, 33, 50, 51). This link between PL profiles and PL turnover allows the detection of changes in PL turnover in the absence of direct turnover rate measurements [34], [35], [53], [54]. High PtdC turnover rates in the resting state allow cells to efficiently switch to PtdC accumulation for membranesynthesis when in a growing state (e.g. as soon as they reach the S phase), simply by blocking PtdC degradation [35]. Several lines of evidence indicate that this mechanism is crucial to normal cell proliferation [54]. In light of this model, increased PtdC accumulation in the Mecp2-null mouse brain, in conjunction with decreased levels of the PtdC degradation product, lyso-PtdC, as well as increased PC/GPC ratios, indicates a reduced ability to degrade PtdC, resulting in restricted PtdC production in cells when in a growing state [35].
###end p 59
###begin p 60
(2.25 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
###xml 28 32 28 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Westergaard1">[37]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Sokal1">[52]</xref>
###xml 875 885 875 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">discussion</xref>
###xml 911 920 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s005">Figure S1</xref>
###xml 1091 1100 1091 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000157.s005">Figure S1</xref>
###xml 1428 1435 1428 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
The PAF cycle (adapted from [37]). Levels of metabolites that were increased (decreased) in the brains of Mecp2-deficient mice vs. controls are indicated by upward (downward) arrows. The concentration of underlined metabolites did not vary between the two groups. The first step in PAF generation is the formation of lyso-PAF from AAPtdC (I). AAPtdC can then be resynthesized from lyso-PAF, potentially via lyso-PtdC (II). Subsequently, lyso-PAF needs to be regenerated either by phospholipolysis (III), or by forming PtdEplasm from AAPtdC (IV). AAPtdC levels were significantly increased in the brains of Mecp2-deficient mice vs. controls, indicating reduced AAPtdC degradation and/or enhanced AAPtdC resynthesis from lyso-PAF [52]. Of these two mechanisms, a decrease in AAPtdC degradation is more likely, given that also PtdC accumulated due to decreased degradation (see discussion of PL turnover above and Figure S1). The second step in PAF formation is the acetylation of lyso-PAF (V), with an alternative route being de novo synthesis (VI) in analogy to the Kennedy pathway for PtdC (Figure S1). In de novo synthesis (VI), choline is phosphorylated and PC is transferred via CDP-choline to alkyl-acetylglycerol. Finally, the cycle is completed by the degradation of PAF to lyso-PAF (VII). Overall, our results are consistent with an altered PAF remodeling pathway in Mecp2-deficient brain, where AAPtdC accumulates while de novo PAF formation may be increased. Further experiments have to reveal whether PAF levels or turnover rates are indeed changed.
###end p 62
###begin p 63
(0.07 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 440 441 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000157-Stanimirovic1">[42]</xref>
###xml 297 302 <span type="species:ncbi:9606">girls</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
The glutamate-glutamine cycle. The excitatory neurotransmitter, glu, is synthesized in neurons from glutamine by way of glutaminase (E.C. 3.5.1.2) activity. After being released from neurons, glutamate is removed by glial Excitatory Amino Acid Transporters (EAAT) that are increased in younger RS girls (thick arrow), and is taken up by astrocytes together with sodium through an energy-dependent pump. Since an increase in intracellular Na+ by cotransport with glutamate stimulates Na,K-ATPase, oxygen consumption, and glucose utilization in astrocytes, glutamate release from neurons causes an increase in metabolic activity in the surrounding glia [42]. Elevated glutamine levels (arrow) and glutamine/glutamate ratios in the brains of Mecp2-deficient mice compared to controls, at insignificant glutamate changes (underlined), are potentially due to enhanced conversion of glutamate to glutamine by glutamine synthetase (E.C. 6.3.1.2) in astrocytes, accompanied by increased glutamate synthesis via the citric acid cycle (thick arrows).
###end p 65
###begin p 66
(2.25 MB TIF)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Uber ein eigenartiges hirnatrophisches Syndrom bei Hyperammonamie im Kindesalter.
###end article-title 69
###begin article-title 70
###xml 87 92 <span type="species:ncbi:9606">girls</span>
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
###end article-title 70
###begin article-title 71
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
###end article-title 71
###begin article-title 72
Rett syndrome and MeCP2: linking epigenetics and neuronal function.
###end article-title 72
###begin article-title 73
###xml 21 27 <span type="species:ncbi:9606">humans</span>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
MeCP2 dysfunction in humans and mice.
###end article-title 73
###begin article-title 74
Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence.
###end article-title 74
###begin article-title 75
Rett syndrome neuropathology review 2000.
###end article-title 75
###begin article-title 76
Neuroanatomy of Rett syndrome: a volumetric imaging study.
###end article-title 76
###begin article-title 77
Neuroanatomy in Rett syndrome: cerebral cortex and posterior fossa.
###end article-title 77
###begin article-title 78
An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001.
###end article-title 78
###begin article-title 79
Head growth in Rett syndrome.
###end article-title 79
###begin article-title 80
Magnetic resonance imaging and clinical findings examined in adulthood-studies on three adults with Rett syndrome.
###end article-title 80
###begin article-title 81
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome.
###end article-title 81
###begin article-title 82
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
###end article-title 82
###begin article-title 83
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
###end article-title 83
###begin article-title 84
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome.
###end article-title 84
###begin article-title 85
MeCP2-dependent transcriptional repression regulates excitatory neurotransmission.
###end article-title 85
###begin article-title 86
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.
###end article-title 86
###begin article-title 87
A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth.
###end article-title 87
###begin article-title 88
Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism.
###end article-title 88
###begin article-title 89
Proton MR spectroscopy in Rett syndrome.
###end article-title 89
###begin article-title 90
Neuroimaging studies in Rett syndrome.
###end article-title 90
###begin article-title 91
Rett syndrome: 1H spectroscopic imaging at 4.1 Tesla.
###end article-title 91
###begin article-title 92
Does genotype predict phenotype in Rett syndrome?
###end article-title 92
###begin article-title 93
From metabolic to metabolomic NMR spectroscopy of apoptotic cells.
###end article-title 93
###begin article-title 94
Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
###end article-title 94
###begin article-title 95
Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review.
###end article-title 95
###begin article-title 96
###xml 25 31 <span type="species:ncbi:10090">murine</span>
In situ accessibility of murine macrophage gangliosides.
###end article-title 96
###begin article-title 97
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1.
###end article-title 97
###begin article-title 98
Membrane cerebral lipids in Rett syndrome.
###end article-title 98
###begin article-title 99
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Cerebrospinal fluid gangliosides in patients with Rett syndrome and infantile neuronal ceroid lipofuscinosis.
###end article-title 99
###begin article-title 100
Rett syndrome: abnormal membrane-bound lamellated inclusions in neurons and oligodendroglia.
###end article-title 100
###begin article-title 101
Cellular responses to excess phospholipid.
###end article-title 101
###begin article-title 102
Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase.
###end article-title 102
###begin article-title 103
Neurobiology of Rett syndrome.
###end article-title 103
###begin article-title 104
Metabolism and release of glutamate in cerebellar granule cells cocultured with astrocytes from cerebellum or cerebral cortex.
###end article-title 104
###begin article-title 105
The problem of astrocyte identity.
###end article-title 105
###begin article-title 106
Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor.
###end article-title 106
###begin article-title 107
Neurobiology of Rett syndrome: a genetic disorder of synapse development.
###end article-title 107
###begin article-title 108
###xml 119 122 <span type="species:ncbi:10116">rat</span>
Role of glutamate receptors and glutamate transporters in the regulation of the glutamate-glutamine cycle in the awake rat.
###end article-title 108
###begin article-title 109
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Stimulation of glutamate uptake and Na,K-ATPase activity in rat astrocytes exposed to ischemia-like insults.
###end article-title 109
###begin article-title 110
Glutamine and glutamate-their central role in cell metabolism and function.
###end article-title 110
###begin article-title 111
Contribution of extracellular glutamine as an anaplerotic substrate to neuronal metabolism: a re-evaluation by multinuclear NMR spectroscopy in primary cultured neurons.
###end article-title 111
###begin article-title 112
Use of NMR spectroscopy for the study of ammonia metabolism in astrocytes and neurons: role of glutamine synthesis in astrocytes.
###end article-title 112
###begin article-title 113
###xml 85 88 <span type="species:ncbi:10116">rat</span>
The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo.
###end article-title 113
###begin article-title 114
Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.
###end article-title 114
###begin article-title 115
###xml 19 24 <span type="species:ncbi:9606">human</span>
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.
###end article-title 115
###begin article-title 116
###xml 57 61 <span type="species:ncbi:10090">mice</span>
An altered neonatal behavioral phenotype in Mecp2 mutant mice.
###end article-title 116
###begin article-title 117
Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts.
###end article-title 117
###begin article-title 118
The Kolmogorov-Smirnov test for normality with mean and variance unknown.
###end article-title 118
###begin article-title 119
Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells.
###end article-title 119
###begin article-title 120
Distribution of CTP:phosphocholine cytidylyltransferase (CCT) isoforms. Identification of a new CCTbeta splice variant.
###end article-title 120
###begin article-title 121
###xml 51 56 <span type="species:ncbi:9606">human</span>
Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.
###end article-title 121
###begin title 122
Figures and Tables
###end title 122
###begin p 123
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 579 582 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myo</italic>
###xml 607 608 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 632 633 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 673 679 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scyllo</italic>
###xml 685 691 681 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scyllo</italic>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Typical high-resolution 1H NMR spectrum of the brain extract from a Mecp2-deficient mouse (water-soluble metabolites). The entire spectral region of interest (upper left spectrum) as well as magnified subregions are shown. Creatinine (Crn) was not quantified since the weak singlet was not sufficiently separated from other peaks forming a broad hump between 3.01 and 3.06 ppm. Abbreviations: ac, acetate; ala, alanine; asp, aspartate; Cho, choline; Cr, creatine; GABA, gamma-aminobutyrate; gln, glutamine; glu, glutamate; gly, glycine; GPC, glycerophosphocholine; lac, lactate; myo-Ins, myo-inositol; NAA, N-acetylaspartate; NANA, N-acetylneuraminate; PC, phosphocholine; scyllo-Ins, scyllo-inositol; suc, succinate; tau, taurine.
###end p 123
###begin p 124
###xml 24 26 24 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
###xml 511 516 511 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 583 588 583 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasm</sub>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Typical high-resolution 31P NMR spectrum of the brain extract from a Mecp2-deficient mouse (phospholipids). The entire PL region (upper left spectrum) as well as magnified subregions are shown. Processing parameters were varied to highlight important spectral details. Abbreviations: AAPtdC, alkyl-acyl-phosphatidylcholine; AAPtdE, alkyl-acyl-phosphatidylethanolamine; CL, cardiolipin; PLx,y, unassigned phospholipids; PtdI, phosphatidylinositol; PtdA, phosphatidic acid; PtdC, (diacyl)phosphatidylcholine; PtdCplasm, choline plasmalogen; PtdE, (diacyl)phosphatidylethanolamine; PtdEplasm, ethanolamine plasmalogen; PtdG, phosphatidylglycerol; PtdS, phosphatidylserine; SM, sphingomyelin.
###end p 124
###begin title 125
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Metabolite levels in Mecp2-/y and control mouse brain (micromol/g wet weight, and molar ratios for selected metabolites)
###end title 125
###begin p 126
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mecp2</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 162 183 162 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
The number of samples per group was n = 3 or 4 for controls or Mecp2-/y mice, respectively. Statistical significance was determined by a Mann-Whitney U test (see Materials and Methods). Asterisks indicate p<0.05 (significance). Results are expressed as mean+/-standard deviation.
###end p 126
###begin title 127
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Metabolite levels in Mecp2-/y and control mouse brain (micromol/g wet weight, and molar ratios for selected metabolites)
###end title 127
###begin p 128
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 113 134 113 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
The number of samples per group was n = 4. Statistical significance was determined by a Mann-Whitney U test (see Materials and Methods). Asterisks indicate p<0.05 (significance). PLx and PLy represent unidentified PL classes. Results are espressed as mean+/-standard deviation.
###end p 128
###begin p 129
###xml 148 156 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">relative</italic>
###xml 177 180 177 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tot</sub>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
a: An outlier presenting an extremely low value has been omitted from this group. With the outlier included, p values would be at ca. 0.1; however, relative PtdC levels (PtdC/PLtot) still show a significant difference between groups (p = 0.043, Mann-Whitney U test).
###end p 129
###begin p 130
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 130
###begin p 131
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Financial support from the following institutions is gratefully acknowledged: CNRS (Centre National de la Recherche Scientifique), Programme Interdisciplinaire CNRS-CEA Imagerie du Petit Animal, Institut Universitaire de France, ACI 2003 (Action Concertee Initiative Plates-formes d'explorations fonctionnelles thematisees). These sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.
###end p 131

